Pharmacokinetics of ciprofloxacin in cystic fibrosis (Q33741046)

29 July 2017

title

Pharmacokinetics of ciprofloxacin in cystic fibrosis (English)

1 reference

29 July 2017

0 references

1 reference

R L Davis

1 reference

29 July 2017

J R Koup

1 reference

29 July 2017

J Williams-Warren

1 reference

29 July 2017

A Weber

1 reference

29 July 2017

L Heggen

1 reference

29 July 2017

D Stempel

1 reference

29 July 2017

A L Smith

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 1987

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

915-919

1 reference

Pharmacokinetics and tissue penetration of ciprofloxacin

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Pharmacokinetics of intravenously administered ciprofloxacin

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Antibiotic use in cystic fibrosis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

In vitro activity of ciprofloxacin (Bay o 9867)

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

A new prognostic score and clinical evaluation system for cystic fibrosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Quantitation of ciprofloxacin in body fluids by high-pressure liquid chromatography

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

The antipyrine test in clinical pharmacology: Conceptions and misconceptions

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284211

Ciprofloxacin pharmacokinetics in patients with cystic fibrosis

30 October 2018

1 reference

12 December 2020

Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis

1 reference

12 December 2020

The Measurement of Glomerular Filtration Rate and Effective Renal Plasma Flow in Man by Iothalamate 125 I and Iodopyracet 131 I

1 reference

12 December 2020

Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking

1 reference

12 December 2020

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

1 reference

12 December 2020

Simplified high performance liquid chromatographic quantitation of antipyrine

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers

1 reference

12 December 2020

Quantitation of iothalamate in serum and urine by high-performance liquid chromatography

1 reference

12 December 2020

Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.31.6.915

1 reference

29 July 2017

1 reference

29 July 2017

1 reference